Loading...

DMS Imaging SA

DMSIM.BR•EURONEXT
Healthcare
Biotechnology
€0.02
€0.001(6.90%)

DMS Imaging SA (DMSIM.BR) Stock Overview

Explore DMS Imaging SA’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 61.7/100

Key Financials

Market Cap23.1M
P/E Ratio-4.14
EPS (TTM)$0.18
ROE-0.57%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$0.01

DMSIM.BR Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of DMS Imaging SA (DMSIM.BR) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.01.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -4.14 and a market capitalization of 23.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Stats data is not available for DMSIM.BRStats details for DMSIM.BR are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for DMSIM.BRAnalyst Recommendations details for DMSIM.BR are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

DMS Imaging SA, a biopharmaceutical company, focuses on the research, development, and commercialization of immunotherapy products for the treatment of allergies in Belgium. Its lead product is gp-ASIT+, which is in the Phase III trial for the treatment of grass pollen. The company is also developing hdm-ASIT+ for the treatment of house dust mite allergy; and pnt-ASIT+ for the treatment of peanut allergy. The company was formerly known as ASIT Biotech S.A. and changed its name to DMS Imaging SA in February 2022. DMS Imaging SA was incorporated in 1997 and is based in Liege, Belgium.

CEO

Frank Hazevoets

Employees

118

Headquarters

7 Rue des Chasseurs Ardennais, Liège

Founded

2016

Frequently Asked Questions

;